Back to Search
Start Over
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.
- Source :
- JAMA Dermatology; May2022, Vol. 158 Issue 5, p552-557, 6p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 21686068
- Volume :
- 158
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- JAMA Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 157006000
- Full Text :
- https://doi.org/10.1001/jamadermatol.2022.0354